
Tasigna, also known by its generic name Nilotinib, is a medication used to treat certain types of blood cancers, specifically chronic myeloid leukemia (CML). It works by inhibiting specific proteins that contribute to the growth of cancer cells.
Tasigna targets and blocks the activity of the BCR-ABL tyrosine kinase, an enzyme that is abnormally active in CML. By inhibiting this enzyme, Tasigna helps to prevent the proliferation of cancerous cells and promotes their death.
Common side effects may include nausea, headaches, fatigue, and skin rash. More serious side effects can occur, such as heart problems or liver issues. It is important to discuss any side effects with your healthcare provider.
Tasigna should not be used by individuals with a known hypersensitivity to Nilotinib or any of its components. Patients with certain heart conditions or those who are pregnant or breastfeeding should consult their doctor before use.
Tasigna is typically taken twice daily, with or without food. It is crucial to follow your healthcare provider's instructions regarding dosage and timing to ensure the best possible outcome.
Tasigna (Nilotinib) is a significant treatment option for those diagnosed with chronic myeloid leukemia. Always consult with a healthcare professional for personalized medical advice and to discuss any potential risks and benefits associated with this medication.